8-K

CELESTICA INC 8-K Report (Oct 25, 2022)

Filed October 25, 2022For Securities:CLS

Summary

Celestica Inc. has filed a Form 6-K on October 25, 2022, reporting on its financial performance and condition for the three and nine months ended September 30, 2022. This report primarily includes the Management's Discussion and Analysis (MD&A) and the Unaudited Interim Condensed Consolidated Financial Statements, crucial documents for investors to assess the company's operational and financial health. The filing provides insights into Celestica's financial results, operational strategies, and outlook. Investors should pay close attention to the details within the MD&A and financial statements to understand revenue trends, profitability, liquidity, and any significant risks or uncertainties the company may be facing. The inclusion of Sarbanes-Oxley certifications further underscores the company's commitment to financial transparency and regulatory compliance.

Key Highlights

  • 1Filing Date: October 25, 2022.
  • 2Report Type: Form 6-K (Report of Foreign Private Issuer).
  • 3Reporting Period: Three and nine months ended September 30, 2022.
  • 4Key Documents Included: Management's Discussion and Analysis (MD&A) and Unaudited Interim Condensed Consolidated Financial Statements.
  • 5Incorporation by Reference: Information from exhibits is incorporated into effective registration statements.
  • 6Sarbanes-Oxley Certifications: CEO and CFO certifications provided under Sections 302 and 906.

Frequently Asked Questions

The primary purpose of this Form 6-K filing is to provide investors with updated financial information, specifically the Management's Discussion and Analysis (MD&A) and the Unaudited Interim Condensed Consolidated Financial Statements for the third quarter and the first nine months of 2022. As a foreign private issuer, Celestica uses this form to report material information to the SEC.

Investors can find detailed insights into Celestica's financial performance, including revenue, profitability, cost of goods sold, operating expenses, and net income. The MD&A will discuss significant trends, factors affecting results, liquidity, capital resources, and any known trends or uncertainties. The financial statements will provide the quantitative data, including balance sheets, income statements, and cash flow statements.

The inclusion of CEO and CFO certifications under Sections 302 and 906 of the Sarbanes-Oxley Act (SOX) demonstrates the company's commitment to certifying the accuracy and completeness of its financial reports. This is a standard requirement for U.S. public companies and foreign private issuers listing on U.S. exchanges, aimed at enhancing corporate accountability and financial transparency.